Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00485654 · ClinicalTrials.gov registry record
Racial Distribution of Heterotaxy Syndrome
A clinical trial, sponsored by Children's Healthcare of Atlanta.
- Terminated
- Registry status
- 65
- Enrollment target
NCT00485654: Clinical Trial study, sponsored by Children's Healthcare of Atlanta.
NCT00485654 is a clinical trial that was terminated before completion, run by Children's Healthcare of Atlanta. The registered enrollment target is 65 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00485654 was terminated before completion, sponsored by Children's Healthcare of Atlanta.
- TERMINATED
- Registry status
- 65 participants
- Enrollment target
Study Summary
Heterotaxy syndrome is a heterogeneous disease that is the result of a failure of normal right-left lateralization of the abdominal and thoracic organs during development. The major clinical manifestations include intestinal malrotation, functional asplenia and complex cyanotic heart disease. Hypothesis: There exists a yet, un-recognized, racial distribution in heterotaxy syndrome.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 1990-01 |
| Est. Completion | 2008-02 |
Why NCT00485654 stopped before completion
NCT00485654 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 65 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00485654 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00485654 about?
NCT00485654 is a clinical study titled "Racial Distribution of Heterotaxy Syndrome". Heterotaxy syndrome is a heterogeneous disease that is the result of a failure of normal right-left lateralization of the abdominal and thoracic organs during development. The major clinical manifestations include intestinal malrotation, functional asplenia and complex cyanotic heart disease. Hypot...
What is the current status of trial NCT00485654?
This trial is currently terminated. The enrollment target is 65 participants. The study started on 1990-01. Estimated completion is 2008-02.
Who is sponsoring clinical trial NCT00485654?
This trial is sponsored by Children's Healthcare of Atlanta, which has 80 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03366116 · 65 participants · Phase 1
5-aza-4'-Thio-2'-Deoxycytidine (Aza-TdC) in People With Advanced Solid Tumors
- NCT03603730 · 65 participants · NA
Vagal Nerve Stimulation for Functional Dyspepsia and Gastroparesis
- NCT03796559 · 65 participants · NA
Magseed Enabled Long-Term Localization of Axillary Lymph Nodes
- NCT03993106 · 65 participants · Phase 2
A Study of sEphB4-HSA in Kaposi Sarcoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia